120 related articles for article (PubMed ID: 11874221)
1. Interferon-induced depression treated with citalopram.
Farah A
J Clin Psychiatry; 2002 Feb; 63(2):166-7. PubMed ID: 11874221
[No Abstract] [Full Text] [Related]
2. Escitalopram ameliorates prolonged depression with psychotic features induced by interferon therapy for hepatitis C infection: report of 2 cases.
Kajitani K; Kanba S
Psychosomatics; 2013; 54(5):506-7. PubMed ID: 23845321
[No Abstract] [Full Text] [Related]
3. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M
Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286
[TBL] [Abstract][Full Text] [Related]
4. CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
Klein MB; Cooper C; Brouillette MJ; Sheehan NL; Benkelfat C; Annable L; Weston F; Kraus D; Singer J;
Contemp Clin Trials; 2008 Jul; 29(4):617-30. PubMed ID: 18262853
[TBL] [Abstract][Full Text] [Related]
5. [Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].
Montes ML; Fraile JM; González JJ; Arribas JR
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):60-1. PubMed ID: 19218008
[No Abstract] [Full Text] [Related]
6. Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.
Klein MB; Lee T; Brouillette MJ; Sheehan NL; Walmsley S; Wong DK; Conway B; Hull M; Cooper C; Haidar S; Vezina S; Annable L; Young S; Zubyk W; Singer J
HIV Clin Trials; 2014; 15(4):161-75. PubMed ID: 25143025
[TBL] [Abstract][Full Text] [Related]
7. Five cases of interferon-alpha-induced depression treated with antidepressant therapy.
Gleason OC; Yates WR
Psychosomatics; 1999; 40(6):510-2. PubMed ID: 10581980
[No Abstract] [Full Text] [Related]
8. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine for the prevention of depression induced by interferon alfa.
Kraus MR; Schäfer A; Scheurlen M
N Engl J Med; 2001 Aug; 345(5):375-6. PubMed ID: 11484704
[No Abstract] [Full Text] [Related]
10. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
Morasco BJ; Rifai MA; Loftis JM; Indest DW; Moles JK; Hauser P
J Affect Disord; 2007 Nov; 103(1-3):83-90. PubMed ID: 17292481
[TBL] [Abstract][Full Text] [Related]
11. Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.
Ann Intern Med; 2012 Jul; 157(2):I-40. PubMed ID: 22801693
[No Abstract] [Full Text] [Related]
12. Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals.
Sockalingam S; Sheehan K; Feld JJ; Shah H
Am J Psychiatry; 2015 Jun; 172(6):512-6. PubMed ID: 26029803
[No Abstract] [Full Text] [Related]
13. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
Dursun SM; Devarajan S
Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
[No Abstract] [Full Text] [Related]
14. Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.
Gleason OC; Fucci JC; Yates WR; Philipsen MA
Dig Dis Sci; 2007 Oct; 52(10):2557-63. PubMed ID: 17436092
[TBL] [Abstract][Full Text] [Related]
15. Escitalopram for the prevention of peginterferon-α2a-associated depression.
Schaefer M; Berg T; Sarkar S; Neumann K
Ann Intern Med; 2013 Jan; 158(2):140. PubMed ID: 23318324
[No Abstract] [Full Text] [Related]
16. Escitalopram for the prevention of peginterferon-α2a-associated depression.
Landman GW
Ann Intern Med; 2013 Jan; 158(2):139-40. PubMed ID: 23318323
[No Abstract] [Full Text] [Related]
17. Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.
Diez-Quevedo C; Masnou H; Planas R; Castellví P; Giménez D; Morillas RM; Martín-Santos R; Navinés R; Solà R; Giner P; Ardèvol M; Costa J; Diago M; Pretel J
J Clin Psychiatry; 2011 Apr; 72(4):522-8. PubMed ID: 21034680
[TBL] [Abstract][Full Text] [Related]
18. Lack of desipramine toxicity with citalopram.
Ashton AK
J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
[No Abstract] [Full Text] [Related]
19. Citalopram-induced diplopia.
Dorell K; Cohen MA; Huprikar SS; Gorman JM; Jones M
Psychosomatics; 2005; 46(1):91-3. PubMed ID: 15765832
[No Abstract] [Full Text] [Related]
20. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.
Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC
Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
